1 to 1 forward stock split of the
Company 's common stock. was
formed with the intent to develop and commercialize novel
biotech/pharmaceutical products including vaccines and stem cells based
treatment modalities and to expand through our own research,
collaborations, acquisitions and in-licensing.

business organized

(NWLF): New Life Scientific, Inc. New Life Scientific, Inc has also recently acquired
PharmaTrials International (PTI), a provider of services in the areas of
clinical trials, market research and the regulatory approval of products
for pharmaceutical , biotech and medical device companies worldwide.

associations pharmaceuticals

1 to 1 forward stock split of
the Company's common stock.

category business

Safe Harbor Statements under the Private Securities Litigation Reform Act
of 1965: Those statements contained herein which are not historical are
forward-looking statements, and as such, are subject to risks and
uncertainties that could cause actual operating results to materially
differ from those contained in the forward-looking statements.

oceania other

pharmaceuticals associations

(NWLF): New Life Scientific , Inc. New Life Scientific utilizes
its strategic geographical positioning in Europe to seek undiscovered ,
emerging and under-valued biotechnologies in the countries of Eastern
Europe, with the further intent of their commercialization. Novo Life Scientific, in
conjunction with IMBG, highly regarded for its extensive knowledge and
expertise in the fields of molecular cell biology and molecular genetics
research, intends to develop and market certain stem cell related products
and therapies.

pharmaceutical scientific

was
formed with the intent to develop and commercialize novel
biotech/pharmaceutical products including vaccines and stem cells based
treatment modalities and to expand through our own research,
collaborations , acquisitions and in-licensing.

contain asia

PRESS RELEASE New Life Scientific Announces Official Record Date for 1.1 to 1 Stock Split and New Symbol NWLS

Each shareholder of record at the close of
business on January 25, 2006, will receive 1.

About New Life Scientific, Inc.

asia other

PRESS RELEASE New Life Scientific Board Approves Forward Stock Split

This category should contain trade associations and other organized groups focused on biotechnology and pharmaceuticals businesses.

societies pharmaceuticals

http://www.

pharmaceutical businesses

New Life Scientific, Inc (OTC BB: NWLF), today
the Board of Directors had authorized a 1.newlifesci. Such
statements include, but are not limited to , certain delays that are beyond
the company's control, with respect to market acceptance of new
technologies , or product delays in the testing and evaluation of products,
and other risks, as detailed in the company's periodic filings with the
Securities and Exchange Commission. Such
statements include , but are not limited to, certain delays that are beyond
the company's control, with respect to market acceptance of new
technologies, or product delays in the testing and evaluation of products,
and other risks, as detailed in the company's periodic filings with the
Securities and Exchange Commission .

scientific trade

organized europe

The new symbol on January 25, 2006 will be NWLS.

Safe Harbor Statements under the Private Securities Litigation Reform Act
of 1965: Those statements contained herein which are not historical are
forward-looking statements, and as such, are subject to risks and
uncertainties that could cause actual operating results to materially
differ from those contained in the forward-looking statements .

groups pharmaceutical

associations oceania

1 shares for every share held
on the record date.

biology trade

com

NWLF recently acquired Novo Life Scientific (Ukraine), the holder of a
cooperation agreement with the Institute of Molecular Biology and Genetics
of the Ukrainian Academy of Sciences (IMBG). New Life Scientific, Inc has also recently acquired
PharmaTrials International (PTI), a provider of services in the areas of
clinical trials , market research and the regulatory approval of products
for pharmaceutical, biotech and medical device companies world wide.

New Life Scientific, Inc (OTC BB: NWLF), today
announced the Official Record Date for the 1.

societies contain

New Life Scientific utilizes
its strategic geographical positioning in Europe to seek undiscovered,
emerging and under-valued biotechnologies in the countries of Eastern
Europe, with the further intent of their commercialization.

NWLF recently acquired Novo Life Scientific (Ukraine), the holder of a
cooperation agreement with the Institute of Molecular Biology and Genetics
of the Ukrainian Academy of Sciences (IMBG).

business pharmaceutical

The split will require any existing shareholder to
tender their current shares in order to receive their forward split shares.

societies groups

pharmaceuticals business

trade category

About New Life Scientific, Inc. Novo Life Scientific, in
conjunction with IMBG, highly regarded for its extensive knowledge and
expertise in the fields of molecular cell biology and molecular genetics
research , intends to develop and market certain stem cell related products
and therapies.